Oncotelic Therapeutics (NASDAQ: ONCT) Partners to Advance AI-Driven Robotics Platform

April 2, 2026

Expert Analysis Oncotelic Therapeutics, Inc. (NASDAQ: ONCT) is positioning itself at the forefront of biotechnology innovation by integrating AI-driven technologies into its oncology-focused platforms. This collaboration reflects a strategic move to leverage advanced robotics enhanced by artificial intelligence, aiming to streamline and optimize the production processes within clinical and manufacturing environments. The partnership highlights how Oncotelic Therapeutics (NASDAQ: ONCT) seeks to combine its clinical expertise with cutting-edge technology to create…

Read More >>